KR7298380007
KR7298380007
ABL Bio
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 2.69T EUR | 5.68T EUR | 10.08T EUR | 11.03T EUR |
Enterprise Value | 2.58T EUR | 5.57T EUR | 9.95T EUR | 10.97T EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | -- | -- | -- | -- |
Price to Sales | 78.39x | 165.76x | 111.64x | 142.84x |
Price to Book | -- | 33.14x | 55.82x | 71.26x |
EV/Revenue | 75.2x | 162.56x | 110.19x | 142.1x |
EV/EBITDA | -31.37x | -- | -- | -- |
Price to FCF (P/FCF) | -- | -- | 1,567.34x | -- |
EV/FCF | -- | -- | 1,546.94x | -- |
FCF Yield | -1.08% | -0.83% | 0.06% | -0.24% |